Table 1 Patient Characteristics
Characteristic | Number | % |
|---|---|---|
Number of patients | 38 | 100% |
Sex | ||
Male | 22 | 58% |
Female | 16 | 42% |
Age (years) | ||
Median | 60 | |
Range | 27-85 | |
ECOG PS at inclusion | ||
0 | 28 | 74% |
1 | 10 | 26% |
2 | 0 | 0% |
3 | 0 | 0% |
ECOG PS at treatment initiation | ||
0 | 23 | 70% |
1 | 8 | 24% |
2 | 1 | 3% |
3 | 1 | 3% |
Staging at study entry | ||
IIIB - N2c | 5 | 13% |
IIIC - N3 | 6 | 16% |
IV - M1a | 16 | 42% |
IV - M1b | 10 | 26% |
IV - M1c | 1 | 3% |
Number of organs involved at baseline | ||
Median (range) | 1 (1-4) | |
1 | 27 | 71% |
2 | 8 | 21% |
> 2 | 3 | 8% |
Organs involved | ||
Local recurrence | 2 | 5% |
Skin metastasis | 18 | 47% |
Lymph node | 11 | 29% |
Lung metastasis | 17 | 45% |
Prior therapies | ||
Prior radiotherapy | 7 | 18% |
Prior immunotherapy | 20 | 53% |
Prior immunotherapy and chemotherapy | 7 | 18% |
Prior systemic chemotherapy | 17 | 45% |
Number of prior chemotherapy lines; Median (range) | 1 (0-4) | |
Prior Isolated Limb Perfusion | 6 | 16% |